论文部分内容阅读
目的:探究在采用内镜进行食管胃静脉曲张破裂出血治疗的影响因素因素以及临床治疗效果。方法:选取自2010年8月至2013年9月收治入院的食管胃静脉曲张破裂出血的患者62例,上述患者均进行内镜下食管胃曲张静脉的套扎以及硬化剂注射治疗,在术后对患者进行随访观察,将上述62例患者按照疾病的转归分为两组,即死亡组(15例)和存活组(47例)。分析上述62例患者的一般资料以及临床病例资料(影像学检查、生化指标等),分析两组患者的上述资料的差异性,进一步分析采用内镜治疗食管胃静脉曲张破裂出血的临床治疗效果以及影响因素。结果:通过对上述患者的一般资料以及临床病例资料分析得出,两组患者在年龄、出血量、腹水量、术后感染、肝功能、白蛋白、凝血酶原时间以及治疗的方法均存在显著的差异(P<0.05),具有统计学意义。结论:研究表明经内镜治疗后影响患者预后的因素有、早期再出血、白蛋白、术后感染等,其中白蛋白水平是患者的自我保护因素,其他两种因素为导致患者再次出血的重要危险因素。
Objective: To explore the influencing factors and clinical effects of endoscopic esophagogastric variceal bleeding treatment. Methods: Totally 62 patients with esophagogastric variceal bleeding admitted to hospital from August 2010 to September 2013 were enrolled in this study. All patients underwent endoscopic esophagogastric varices ligation and sclerotherapy, After the follow-up observation of the patients, the above 62 patients were divided into two groups according to the disease outcome: death group (15 cases) and survival group (47 cases). Analysis of the above-mentioned 62 cases of patients with general information and clinical case data (imaging studies, biochemical indicators, etc.), analysis of the two groups of patients the difference of the above data to further analyze the clinical treatment of endoscopic esophageal variceal bleeding clinical efficacy and Influencing factors. Results: Based on the above data and clinical data, we found there were significant differences in age, blood loss, ascites volume, postoperative infection, liver function, albumin, prothrombin time and treatment methods The differences (P <0.05), with statistical significance. Conclusion: The study shows that endoscopic therapy affect the prognosis of patients with factors such as early rebleeding, albumin, postoperative infection, albumin level is the patient’s self-protection factor, the other two factors lead to re-bleeding in patients with the important Risk factors.